The Safety and Effectiveness of 524W91

NCT00002335 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Emtricitabine

Sponsor

Glaxo Wellcome